Third, indirect methods were used to assess height, weight, and other anthropometric indices due to resource constraints, which may have introduced measurement inaccuracies
GLP-1 therapy is changing the game in the prevention and treatment of many chronic conditions
[3] Monitoring phenytoin levels in the ICU can be challenging, especially if your lab does not provide rapid turnaround times for free phenytoin levels
In a large 56-week clinical trial that evaluated liraglutide in individuals who were overweight or had obesity, as well as had diabetes or prediabetes, participants reported statistically significant weight loss compared with those who took the placebo at the end of the study
Bowel Obstruction: This is a physical blockage in the small or large intestine
Monitoring and titration If you are microdosing GLP-1 medications, it is important to track the side effects carefully, particularly gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation